Sara Sarhangian, FNP

Sara Sarhangian practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Sara Sarhangian's NPI, 1861873986, was assigned on June 15, 2015. Sara Sarhangian holds California license 95001872.

Sara Sarhangian's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Sara Sarhangian's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Sara Sarhangian is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Medical Group (UCLA Health).

Dmand AI tracks the electronic health record (EHR) system at each site where Sara Sarhangian practices, 2 sites in all. Vendor and product names are available with a free account.

Family is Sara Sarhangian's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Sara Sarhangian is licensed in California.

CMS data shows 107 Medicare services from Sara Sarhangian across 1 procedure code in 2024, for 61 Medicare patients. Medicare paid $10,877 for them.

CMS counts 61 Medicare patients who saw Sara Sarhangian in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 44% are also on Medicaid. Their average risk score is 3.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sara Sarhangian's median patient age at 59, with 50% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Sara Sarhangian for performance year 2024, reported as part of a group. Sara Sarhangian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 15 general payments to Sara Sarhangian from 11 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $367.